The Annals New | Pharmaco Epidemiology and Therapeutic Risk Management
home help contact us subscription past issues search current issue
 QUICK SEARCH:   [advanced]


     


The Annals of Pharmacotherapy: Vol. 29, No. 5, pp. 531-533.
© 1995 Harvey Whitney Books Company.
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Young, E.
Right arrow Articles by Frazier, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Young, E.
Right arrow Articles by Frazier, J.


Research Articles

Vitamin E and the risk of coronary artery disease

EG Young and JL Frazier

Before the widespread use of vitamin E in any dosage regimen can be recommended for the prevention of CAD, more information on its efficacy and adverse effects must be obtained. Unfortunately, the results of ongoing studies will not be available for several years. Until then, pharmacists can play a major role in monitoring vitamin E supplementation and educating both patients and other healthcare professionals about its potential role in decreasing the risk of coronary artery disease.





homecopy help contact us subscription past issues search current issue
Copyright © 1995 by Harvey Whitney Books Company.